Literature DB >> 1954171

A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis.

R J King1.   

Abstract

Oestrogens and progestins are important for both the genesis of human breast cancer and growth of those tumours once formed. Their role at different stages of the neoplastic process are reviewed and discussed within the context of a change in sensitivity of epithelial cells during either initiation or promotion stages. Evidence favours, but does not conclusively prove, the view that progestins are the predominant mitogen for normal breast epithelium whilst oestrogen assumes that function in neoplastic epithelium. Alterations in oestrogen receptor levels could provide the key for such a change. There are insufficient data on physiological progestin concentrations to judge their effect on established cancer. Models for steroidal effects on cell proliferation and oestrogen and progestin receptor regulation that are based on endometrial data are not appropriate for breast.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954171     DOI: 10.1016/0960-0760(91)90030-9

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells.

Authors:  J P Wiebe; D Muzia
Journal:  Endocrine       Date:  2001-10       Impact factor: 3.633

3.  Changes in oestrogen, progesterone and epidermal growth factor receptor concentrations and affinities during the oestrous cycle in the normal mammary gland and uterus of dogs.

Authors:  I Donnay; P Wouters-Ballman; N Devleeschouwer; G Leclercq; J Verstegen
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

5.  Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs.

Authors:  G R Rutteman; J A Foekens; H Portengen; J H Vos; M A Blankenstein; E Teske; C J Cornelisse; W Misdorp
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).

Authors:  C Schairer; C Byrne; P M Keyl; L A Brinton; S R Sturgeon; R N Hoover
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

Review 7.  William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

Authors:  R J King
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.

Authors:  Eileen Tremmel; Simone Hofmann; Christina Kuhn; Helene Heidegger; Sabine Heublein; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Sven Mahner; Nina Ditsch; Udo Jeschke; Aurelia Vattai
Journal:  Breast Cancer (Dove Med Press)       Date:  2019-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.